Deadlines for entry / submissions is December 1st, 2021.
All submissions will be judged in December and the presenters of selected abstracts, as well as the top 5 nominated abstracts for the award, will be notified prior to year-end.
We are looking forward to dive into practice-changing discussions through your research!
GUIDES & TIPS
TITLE: Project titles should be dynamic & conclusive, not descriptive.
FORMAT & SECTIONS: Abstracts must not exceed 3000 characters. There is no character limit for posters. The format of submissions should include the following sections: (1) Introduction and Background – including a statement of relevance that provides the rationale for your study; (2) Hypothesis or Objective(s); (3) Methods – including sample size; and, (4) Results & Conclusion
THERAPEUTIC AGENTS, HEALTHCARE PRODUCTS OF SERVICES: If such agents are included in abstracts / posters, use generic, not commercial names. If it is necessary to use trade names, use them from several companies when available and not just those from any single company / entity. Because Medtronic is the sole financial sponsor of these scholarships, submissions related to off-label topics cannot be considered. Additionally, if a poster includes any Medtronic products, it must only include FDA approved use of that product.
ABBREVIATIONS: Standard abbreviations may be used without definition / explanation, however, nonstandard abbreviations must be placed in parentheses after the first use of the word or phrase abbreviated.
REFERENCES: Note these in a designated section separate from the main abstract.
AVOID DUPLICATIVE WORK & COMPLEX GRAPHS: Do not use font or diagrams that are too small or too busy to be easily reviewed. If the abstract has been or is to be submitted to more than one meeting, investigators must include significant new and scientifically meaningful information at the time of submission to WAF. Authors should not ‘split’ data to create several abstracts from one. If splitting is judged to have occurred, prior scores of related abstracts will be reduced, and multiple submissions may even be disqualified.
ABSTRACT LIMITS: There is no limit to the number of abstracts an investigator may submit. If an author’s name appears on more than one submitted abstract, it must be identical on each abstract. If multiple submissions from the same individual(s) are accepted, the submitting individual must be one of the listed co-authors; and, in the event there is a schedule conflict, the presenting author must arrange for a co-author to present should the submission be awarded ‘top submission’. (The submitting author is designated as the primary and presenting author.)
BE CLEAR & CONCISE
GRAMMAR & SPELLING: Proof your submission for accurate grammar and spelling suitable for publication among professionals in attendance at WAF 2022.
JUDGING: All entries will be judged by a panel of five judges comprised of experts in the field of cardiovascular diseases. They will be rating each submission on (1) Novelty / Originality with Scientific Merit; (2) Clarity; (3) Significance / Relevance to Practice; and (4) Methodology (must have facts and data to demonstrate scientific backing). Each of these four assessment areas will carry equal point potential.
SUBMIT COMPLETED ENTRIES ON OR BEFORE WEDNESDAY, DECEMBER 1st to [email protected] with the SUBJECT LINE: WAF ABSTRACT ENTRY. If you wish to nominate your abstract for the “Best Abstract Award” please place the following note at the top of your submission – I would like to nominate my abstract to the “Best Abstract Award”.
We look forward to receiving your application.
All applicants will be entitled to complimentary registration for the
two-day WAF Symposium and all related activities.
Be ready for a great experience and exciting program packed with
information that will help improve your current & future practices!